↓ Skip to main content

Dove Medical Press

The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, March 2019
Altmetric Badge

Mentioned by

twitter
1 X user
reddit
1 Redditor

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
18 Mendeley
Title
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
Published in
Blood and Lymphatic Cancer: Targets and Therapy, March 2019
DOI 10.2147/blctt.s177009
Pubmed ID
Authors

Michael Schieber, Shuo Ma

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 22%
Other 2 11%
Researcher 2 11%
Student > Master 1 6%
Student > Postgraduate 1 6%
Other 0 0%
Unknown 8 44%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 22%
Medicine and Dentistry 3 17%
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Social Sciences 1 6%
Agricultural and Biological Sciences 1 6%
Other 0 0%
Unknown 8 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2020.
All research outputs
#20,963,058
of 25,748,735 outputs
Outputs from Blood and Lymphatic Cancer: Targets and Therapy
#1
of 1 outputs
Outputs of similar age
#285,727
of 369,224 outputs
Outputs of similar age from Blood and Lymphatic Cancer: Targets and Therapy
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 0.5. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,224 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them